Searchable abstracts of presentations at key conferences in endocrinology

ea0044p177 | Obesity and Metabolism | SFEBES2016

Glucocorticoid treatment rapidly increases AgRP and food intake with delayed effects on other metabolic systems

Harno Erika , Davies Alison , Allen Tiffany-Jayne , Sefton Charlotte , Wray Jonathan R , Ramamoorthy Thanuja Gali , Coll Anthony P , White Anne

Glucocorticoids are widely prescribed therapeutic agents, however long term treatment can cause increased morbidity from adverse metabolic events, including weight gain and hyperglycaemia. The mechanisms and site of action which underpin these side-effects are not fully understood. The aim of this study was to characterise phenotypic, biochemical and neurohormonal responses in mice administered corticosterone, with a particular focus on changes seen in the early stages of chro...

ea0044p192 | Obesity and Metabolism | SFEBES2016

RNA-seq of mouse arcuate nuclei reveals pathways perturbed by glucocorticoid treatment

Wray Jonathan , Harno Erika , Davies Alison , Sefton Charlotte , Allen Tiffany-Jayne , Lam Brian Y.H. , Yeo Giles S.H. , White Anne

Glucocorticoids (GCs) are widely prescribed to treat a number of inflammatory and autoimmune conditions. However, patients receiving GCs often develop adverse metabolic effects such as hyperphagia leading to weight gain and hyperglycaemia. Little is known about the central effects of GCs; however they can act in the hypothalamic arcuate nucleus (ARC), a region involved in the integration of other energy regulatory hormones such as leptin, insulin and ghrelin. Therefore, the ai...

ea0039ep8 | Adrenal | BSPED2015

Intravenous Etomidate in the management of hypercortisolaemia due to ectopic ACTH producing thymic neuroendocrine tumor

Arya Ved Bhushan , Irvine Vanessa , Rowlands Helen , Sykes Kim , Nicolin Gary , Drake William , Storr Helen , Davies Justin H

Background: Ectopic-ACTH syndrome (EAS) is an extremely rare cause of Cushing’s syndrome in young children. The intensity of ACTH secretion and hypercortisolaemia is greater in EAS than in Cushing’s disease. Control of hypercortisolaemia represents a key management step while awaiting localization of the ACTH source or in preparation to surgery. Etomidate inhibits cortisol synthesis and its rapid onset of action makes it an ideal medication in severe hypercortisolaem...

ea0059oc3.4 | Obesity & diabetes | SFEBES2018

Knockout of glucocorticoid receptor on AgRP/NPY/GABA (ANG) neurons identifies a potential role for this neuronal population in mediating glucocorticoid–induced insulin resistance in female mice

Harno Erika , Davies Alison , Allen Tiffany-Jayne , Sefton Charlotte , Wray Jonathan R , Coll Anthony P , White Anne

Glucocorticoids (Gcs) are used in the treatment of inflammatory disorders including asthma and rheumatoid arthritis. However, long-term use can cause metabolic side-effects including obesity and diabetes. Previous studies have shown that Gcs increase Agrp expression and that AgRP/NPY/GABA (ANG) neurons can regulate appetite and insulin sensitivity. To investigate the effects of chronic Gc treatment directly on ANG neurons, we crossed AgRP-IRES-Cre with GR...

ea0059p054 | Bone and calcium | SFEBES2018

Risk of bone fracture is not increased in women with TS compared to women with ovarian failure

Pimblett Antoinette , Elliot Jessica , Wilson Jack , Nair Sasha , La Rosa Clementina , Davies Melanie C , Conway Gerard S

Women with Turners Syndrome (TS) have been shown to have reduced bone mineral density (BMD) but there is uncertainty about how this relates to fracture risk. The little data that does exist is conflicting, with one case series finding no difference compared to controls and one survey suggesting an increased risk of fracture particularly of the forearm. Proposed mechanisms for reduced BMD include short stature, oestrogen deficiency and bone dysplasia. In addition, fracture risk...

ea0059p171 | Obesity & metabolism | SFEBES2018

Glucocorticoid-induced metabolic syndrome: establishing the role of AgRP

Sefton Charlotte , Harno Erika , Davies Alison , Allen Tiffany-Jayne , Wray Jonathan R , Coll Anthony P , White Anne

Glucocorticoid (Gc) excess, either from endogenous overproduction in disorders of the hypothalamic-pituitary-adrenal axis or exogenous medical therapy, is recognized to cause adverse metabolic side effects including obesity, hyperphagia, and hyperglycemia. The Gc receptor (GR) is widely expressed in the brain including the hypothalamus which is known to regulate energy balance. We have previously established through the administration of corticosterone (Cort) in the drinking w...

ea0038p218 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Glucocorticoid excess increases hypothalamic AgRP and results in obesity and hyperinsulinaemia in mice

Wray Jonathan , Harno Erika , Davies Alison , Sefton Charlotte , Ramamoorthy Thanuja Gali , Allen Tiffany-Jayne , Coll Anthony P , White Anne

Glucocorticoids (Gcs) are widely prescribed to treat a number of conditions, such as arthritis and asthma. However, patients receiving Gcs often develop metabolic complications such as obesity and hyperglycaemia. The aim of this study was to investigate the molecular mechanisms in the hypothalamus which drive these adverse effects. Male C57BL/6J mice were given ad libitum access to either corticosterone (CORT; 75 μg/ml) or vehicle (V; 1% ethanol) in their drinkin...

ea0038p230 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Maternal overnutrition programs hypothalamic neuropeptides and metabolic syndrome in offspring

Ramamoorthy Thanuja Gali , Allen Tiffany-Jayne , Davies Alison , Harno Erika , Sefton Charlotte , Wray Jonathan , Murgatroyd Christopher , White Anne

Background and objective: The prevalence of obesity is increasing worldwide and it is known that intra-uterine experience can program metabolic disorders. The hypothalamic appetite regulatory system is a key target of developmental programming by maternal nutrition. Therefore, the aim of this study was to investigate the effects of maternal overnutrition on the expression of hypothalamic genes controlling energy homeostasis.Research design: Eight week ol...

ea0038p366 | Reproduction | SFEBES2015

Structured education programme to improve cardiovascular risk in women with polycystic ovary syndrome: SUCCESS-RCT improved physical activity and illness perception

Mani Hamidreza , Khunti Kamlesh , Levy Miles , Bodicoat Danielle , Gray Laura , Barnett Janette , Daly Heather , Howlett Trevor , Davies Melanie

Background: Structured education programmes (SEP) have proved effective in changing illness perception and increasing physical activity (PA) in those with or at risk of diabetes. The SUCCESS–RCT was designed to test such a programme in women with polycystic ovary syndrome (PCOS).Methods: This was a single centre, randomised controlled trial in overweight and obese women with PCOS aimed at increasing their walking activity by 2000 steps/day after 12 ...

ea0058oc4.1 | Oral Communications 4 | BSPED2018

Hydrocortisone granules in capsules for opening: phase 3 trial in children with adrenal insufficiency and long-term safety data

Lewis Alexander , Neumann Uta , Wiegand Susanna , Krude Heiko , Digweed Dina , Voet Bernard , Ross Richard , Davies Madhu , Blankenstein Oliver

Introduction: Children with adrenal insufficiency requiring hydrocortisone rely on compounded adult medication. This study aimed to evaluate the absorption, palatability and safety of Alkindi® (hydrocortisone granules in capsules for opening).Methods: The phase 3 study was an open-label, single-dose study in a total of 24 children (aged 0–6 years) with adrenal insufficiency. Fasted children were given a single dose of Alkindi&#1...